DOP067: Factors influencing infliximab and adalimumab antibody formation and 6 month retrospective follow-up in a Tertiary IBD Centre

DOP067: Faecal calprotectin measurements by IBD patients themselves at home are feasible and provide reliable results compared to the standard lab method

DOP069: A retrospective non-interventional European database analysis assessing adherence and persistence of mild to moderate IBD treatments

DOP069: Dose optimization using drug and antibody levels can benefit 50% patients prescribed anti TNF therapy compared to empiric dose adjustment

DOP070: Perception of the impact of Ulcerative Colitis in the quality of life of patients from Spain. UC-life survey

DOP070: The relationship between vedolizumab drug concentrations at or before week 6 and remission at week 14 in ulcerative colitis patients from GEMINI 1

DOP071: Endoscopic detection of small bowel adenocarcinoma and dysplasia in patients with jejuno-ileal Crohn’s Disease: Prospective study in a cohort of high risk patients (DYDJI Study

DOP071: Tofacitinib plasma concentration monitoring is not needed for optimisation of induction therapy in moderate to severe ulcerative colitis: Results of pooled exposure-response analyses of Phase 3 induction studies

DOP072: Association of ustekinumab trough concentrations with clinical, biochemical and endoscopic outcomes

DOP072: Differentiating neoplastic and non-neoplastic raised lesions (polyps and pseudopolyps) in long-standing Ulcerative Colitis: Results from a prospective systematic study using virtual chromoendoscopy with FICE and the Kudo classification

DOP074: Incidence prediction of fistula formation in England

DOP075: Looking beyond symptoms and disease activity to define disease severity in inflammatory bowel disease: results of an IOIBD specialist panel

DOP075: Persistent dysregulated colonic mucosal gene expression in Ulcerative Colitis patients with endoscopic healing after infliximab or vedolizumab therapy

DOP076: Impact of western diet on short-chain fatty acids production and host susceptibility to intestinal inflammation in a context of Crohn’s Disease

DOP076: A Danish cross-sectional study: Autoimmune and chronic inflammatory disorders associated with Ulcerative Colitis.

DOP077: Involvement of type VI secretion systems in virulence of adherent-invasive Escherichia coli isolated from patients with Crohn’s Disease

DOP077: Immunochip Analysis Identifies Multiple Susceptibility Loci for Collagenous Colitis

DOP078: Abnormal gut homing and activation profile of blood and colonic dendritic cells in paediatric Crohn’s Disease normalises in response to nutritional therapy

DOP078: Risk of malignancy in paediatric inflammatory bowel disease: Results from the DEVELOP registry

DOP079: Pro-inflammatory effect of volcanic ash (v.ash) in a colitis model – is the v. ash or some of its components linked with the IBD epidemiology?